SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-22-034314
Filing Date
2022-06-03
Accepted
2022-06-03 18:11:06
Documents
2
Period of Report
2022-05-25

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2939
2 EX-24 DOCUMENT attachment1.htm EX-24 2141
  Complete submission text file 0001209191-22-034314.txt   6539
Mailing Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043
Business Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043 650-965-7873
IGM Biosciences, Inc. (Issuer) CIK: 0001496323 (see all company filings)

IRS No.: 770349194 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AEGLEA BIOTHERAPEUTICS, INC. 805 LAS CIMAS PARKWAY, SUITE 100 AUSTIN TX 78746
Business Address
Weber Steven (Reporting) CIK: 0001844594 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39045 | Film No.: 22996127